⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28178517 | 0.97 | — | — | |
| SCHEMBL11451788 | 0.97 | — | — | |
| SCHEMBL2830350 | 0.97 | — | — | |
| SCHEMBL8607768 | 0.94 | — | — | |
| SCHEMBL15765884 | 0.81 | HSD17B10 (0.40) | — | |
| SCHEMBL15509338 | 0.79 | HSD17B10 (0.44) | — | |
| SCHEMBL161305 | 0.77 | — | — | |
| SCHEMBL13611580 | 0.76 | — | — | |
| SCHEMBL20648 | 0.76 | — | — | |
| SCHEMBL16668528 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 462 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260015354-A1 | Solid State Forms of Ensifentrine | CIPLA LIMITED (IN) | 2026-01-15 | — | — | US | claimed |
| WO-2024127413-A1 | SOLID STATE FORMS OF ENSIFENTRINE | CIPLA LIMITED (IN) | 2024-06-20 | — | — | WO | claimed |
| US-20240059669-A1 | COCRYSTAL OF A CDK INHIBITOR | AURIGENE ONCOLOGY LIMITED (IN) | 2024-02-22 | — | — | US | claimed |
| EP-4263534-A1 | COCRYSTAL OF A CDK INHIBITOR | Aurigene Oncology Limited (IN) | 2023-10-25 | — | — | EP | claimed |
| CN-116685326-A | Co-crystals of CDK inhibitors | 奥瑞珍肿瘤有限公司 | 2023-09-01 | — | — | CN | claimed |
| EP-4103560-A1 | NOVEL SALTS OF NILOTINIB AND POLYMORPHIC FORMS THEREOF | Cipla Limited (IN) | 2022-12-21 | — | — | EP | claimed |
| WO-2022130304-A1 | COCRYSTAL OF A CDK INHIBITOR | AURIGENE DISCOVERY TECHNOLOGIES LTD. (IN) | 2022-06-23 | — | — | WO | claimed |
| WO-2021161347-A1 | NOVEL SALTS OF NILOTINIB AND POLYMORPHIC FORMS THEREOF | CIPLA LIMITED (IN) | 2021-08-19 | — | — | WO | claimed |
| EP-3595671-A1 | SALTS OF ANTIVIRAL PHOSPHONATE ANALOGUES AND PROCESS FOR PREPARATION THEREOF | Cipla Limited (IN) | 2020-01-22 | — | — | EP | claimed |
| CN-110573163-A | Antiviral phosphonate analog salts and methods of making the same | 奇普拉股份有限公司 | 2019-12-13 | — | — | CN | claimed |
| EP-2331545-A2 | IMPROVED PROCESS FOR PREPARATION OF (2R)-4-OXO-4-[3- (TRIFLUOROMETHYL)-5,6-DIHYDRO [1,2,4]-TRIAZOLO[4,3-A]PYRAZIN- 7(8H)-YL]-L-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE&NEW IMPURITIES IN PREPARATION THEREOF | Cadila Healthcare Limited (IN) | 2011-06-15 | — | — | EP | claimed |
| WO-2010032264-A2 | IMPROVED PROCESS FOR PREPARATION OF (2R)-4-OXO-4-[3- (TRIFLUOROMETHYL)-5,6-DIHYDRO [1,2,4]-TRIAZOLO[4,3-A]PYRAZIN- 7(8H)-YL]-L-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE & NEW IMPURITIES IN PREPARATION THEREOF | CADILA HEALTHCARE LIMITED (IN) | 2010-03-25 | — | — | WO | claimed |
| WO-2008111794-A1 | 4-METHYLIMIDAZOL-5-YLCARBONYLGUANIDINE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PREPARATION METHOD, AND PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF THE ISCHEMIC HEART DISEASES CONTAINING THE SAME AS AN ACTIVE INGREDIENT | KOREA RESERACH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2008-09-18 | — | — | WO | claimed |
| US-6841665-B2 | Method for synthesizing 5β, 6β-epoxides of steroids by a highly β-selective epoxidation of ΔΔ5-unsaturated steroids catalyzed by ketones | THE UNIVERSITY OF HONG KONG (CN) | 2005-01-11 | — | — | US | claimed |
| WO-2003074545-A1 | METHOD FOR SYNTHESIZING 5ß, 6ß-EPOXIDES OF STEROIDS BY A HIGHLY ß-SELECTIVE EPOXIDATION OF Δ5-UNSATURATED STEROIDS CATALYZED BY KETONES | THE UNIVERSITY OF HONG KONG (CN) | 2003-09-12 | — | — | WO | claimed |
| US-20030018188-A1 | Method for synthesizing 5beta, 6beta-epoxides of steroids by a highly beta-selective epoxidation of delta5-unsaturated steroids catalyzed by ketones | UNIVERSITY OF HONG KONG, THE (HK) | 2003-01-23 | — | — | US | claimed |
| WO-2001077135-A1 | PROCESS FOR PREPARING 6-METHYL ERYTHROMYCIN A | CHONG KUN DANG PHARMACEUTICAL CORP. (KR) | 2001-10-18 | — | — | WO | claimed |
| EP-0203652-A2 | Cryogenic process for the removal of acidic gases from mixture of gases by solvents | SNAMPROGETTI S.p.A. (IT) | 1986-12-03 | — | — | EP | claimed |
| US-4108671-A | Dye-based inks with improved vehicles | RICHLIN MILTON | 1978-08-22 | — | — | US | claimed |
| US-4016204-A | ISOMERIZING ETHYL-2-PHENYL-CYCLOPROPANE CARBOXYLATE | NELSON RESEARCH & DEVELOPMENT COMPANY (US) | 1977-04-05 | — | — | US | claimed |